1. Home
  2. VRDN vs DMLP Comparison

VRDN vs DMLP Comparison

Compare VRDN & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • DMLP
  • Stock Information
  • Founded
  • VRDN 2006
  • DMLP 2003
  • Country
  • VRDN United States
  • DMLP United States
  • Employees
  • VRDN N/A
  • DMLP N/A
  • Industry
  • VRDN Medical Specialities
  • DMLP Oil & Gas Production
  • Sector
  • VRDN Health Care
  • DMLP Energy
  • Exchange
  • VRDN Nasdaq
  • DMLP Nasdaq
  • Market Cap
  • VRDN 1.6B
  • DMLP 1.6B
  • IPO Year
  • VRDN N/A
  • DMLP N/A
  • Fundamental
  • Price
  • VRDN $19.64
  • DMLP $33.21
  • Analyst Decision
  • VRDN Strong Buy
  • DMLP
  • Analyst Count
  • VRDN 11
  • DMLP 0
  • Target Price
  • VRDN $37.63
  • DMLP N/A
  • AVG Volume (30 Days)
  • VRDN 1.4M
  • DMLP 132.7K
  • Earning Date
  • VRDN 11-12-2024
  • DMLP 10-31-2024
  • Dividend Yield
  • VRDN N/A
  • DMLP 12.29%
  • EPS Growth
  • VRDN N/A
  • DMLP 4.55
  • EPS
  • VRDN N/A
  • DMLP 2.78
  • Revenue
  • VRDN $302,000.00
  • DMLP $166,454,000.00
  • Revenue This Year
  • VRDN $2.55
  • DMLP N/A
  • Revenue Next Year
  • VRDN N/A
  • DMLP N/A
  • P/E Ratio
  • VRDN N/A
  • DMLP $11.76
  • Revenue Growth
  • VRDN N/A
  • DMLP 14.26
  • 52 Week Low
  • VRDN $11.40
  • DMLP $28.41
  • 52 Week High
  • VRDN $27.20
  • DMLP $35.74
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 49.14
  • DMLP 45.31
  • Support Level
  • VRDN $20.06
  • DMLP $32.00
  • Resistance Level
  • VRDN $23.65
  • DMLP $34.50
  • Average True Range (ATR)
  • VRDN 1.05
  • DMLP 0.88
  • MACD
  • VRDN 0.16
  • DMLP -0.16
  • Stochastic Oscillator
  • VRDN 49.45
  • DMLP 25.66

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests

Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.

Share on Social Networks: